Related Experiment Video
Updated: Nov 8, 2025

05:22
Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
Published on: February 24, 2023
3.7K
Summary
A new catalog reveals genetic vulnerabilities in pediatric tumors, identifying new therapeutic targets unique to childhood cancers. These findings show pediatric cancers rely on specific genes for survival, similar to adult tumors.
Area of Science:
- Oncology
- Genetics
- Cancer Biology
Background:
- Pediatric tumors present unique genetic landscapes compared to adult malignancies.
- Understanding genetic dependencies is crucial for developing targeted cancer therapies.
- The Cancer Dependency Map Project aims to comprehensively map cancer vulnerabilities.
Purpose of the Study:
- To create the first comprehensive catalog of genetic vulnerabilities in pediatric tumors.
- To identify novel therapeutic targets for childhood cancers.
- To compare the genetic dependencies of pediatric and adult tumors.
Main Methods:
- Systematic screening for genetic dependencies across a wide range of pediatric tumor types.
- Analysis of gene expression and mutation data to identify essential genes.
- Comparison of identified vulnerabilities with known cancer gene databases.
Main Results:
- Identification of dozens of potential therapeutic targets in pediatric cancers.
- Discovery of vulnerabilities in genes not previously known to harbor activating mutations.
- Many identified vulnerabilities are unique to childhood cancers.
- Pediatric tumors, despite lower mutational burden, exhibit a similar number of essential gene dependencies as adult tumors.
Conclusions:
- The comprehensive catalog provides a valuable resource for pediatric cancer research.
- New therapeutic strategies targeting identified genetic vulnerabilities can be explored.
- Targeting unique genetic dependencies may overcome resistance in childhood cancers.
Related Concept Videos
Combination Therapies and Personalized Medicine
5.5K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.5K
Cancer Therapies
8.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K
Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Adaptive Mechanisms in Cancer Cells
6.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
Cancer
51.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.5K

